24 research outputs found

    Associations of lipid-related genetic variants with lipid fraction and CAD risk.

    No full text
    <p>Association of coronary artery disease (CAD) risk-increasing alleles of 185 genetic variants with odds of CAD, and with each of low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c) and triglycerides in turn (brightness and size of points: brighter points correspond to stronger associations with CAD risk, larger points correspond to more precise estimates). Note that some points are overlapping.</p

    Causal odds ratios (95% confidence/credible intervals) of coronary artery disease per standard deviation increase in each lipid fraction (low-density lipoprotein cholesterol, LDL-c; high-density lipoprotein cholesterol, HDL-c; and triglycerides), with two-sided p-value for HDL-c.

    No full text
    <p>MR  =  Mendelian randomization.</p>a<p>Derived from Table 3 of Do et al. <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0108891#pone.0108891-Do1" target="_blank">[8]</a></p>b<p>Removing 23 variants having known pleiotropic associations with blood pressure or body mass index.</p><p>Causal odds ratios (95% confidence/credible intervals) of coronary artery disease per standard deviation increase in each lipid fraction (low-density lipoprotein cholesterol, LDL-c; high-density lipoprotein cholesterol, HDL-c; and triglycerides), with two-sided p-value for HDL-c.</p

    DS_10.1177_0272989X17753380 – Supplemental material for Discrete Event Simulation for Decision Modeling in Health Care: Lessons from Abdominal Aortic Aneurysm Screening

    No full text
    <p>Supplemental material, DS_10.1177_0272989X17753380 for Discrete Event Simulation for Decision Modeling in Health Care: Lessons from Abdominal Aortic Aneurysm Screening by Matthew J. Glover, Edmund Jones, Katya L. Masconi, Michael J. Sweeting, Simon G. Thompson, and SWAN Collaborators in Medical Decision Making</p

    Subcohort sampling fractions reported in each of 32 papers included in the review.

    No full text
    <p>Bars are labelled according to the number of the paper in the reference list in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0101176#pone.0101176.s002" target="_blank">Appendix S2</a>.</p

    Pictorial representation of an unstratified case-cohort study design.

    No full text
    <p>Included in the study are a subcohort of individuals randomly sampled from the original cohort, together with all incident cases of the disease of interest. Because the subcohort is a random sample from the whole original cohort, it includes some incident cases. The subcohort sampling fraction is the proportion of individuals in the original cohort who are included in the random subcohort, and is defined at the start of the study.</p

    Causal assumptions as a directed acyclic graph.

    No full text
    <p>Diagram of causal relationships between genetic variants, risk factors (low-density lipoprotein cholesterol, LDL-c; high-density lipoprotein cholesterol, HDL-c; and triglycerides), confounders, and disease (coronary artery disease, CAD). Although confounders (common causes of a risk factor and the outcome) are represented as a single variable for simplicity, each risk factor may have a different set of confounders.</p

    Associations of lipid-related genetic variants with lipid fractions.

    No full text
    <p>Association of coronary artery disease (CAD) risk-increasing alleles of 185 genetic variants with all pairs of low-density lipoprotein cholesterol (LDL-c), high-density lipoprotein cholesterol (HDL-c), and triglycerides (brightness and size of points: brighter points correspond to stronger associations with CAD risk, larger points correspond to more precise estimates). Note that some points are overlapping.</p

    Sensitivity analysis for the correlation parameters (<i>ρ</i><sub>..</sub>) between beta-coefficients for genetic associations with LDL-c (<i>β<sub>L</sub></i>), HDL-c (<i>β<sub>H</sub></i>), triglycerides (<i>β<sub>T</sub></i>) and CAD risk (<i>β<sub>Y</sub></i>): estimates of causal log odds ratios <i>β<sub>L</sub></i>, <i>β<sub>H</sub></i>, and <i>β<sub>T</sub></i> (with standard errors).

    No full text
    <p>Sensitivity analysis for the correlation parameters (<i>ρ</i><sub>..</sub>) between beta-coefficients for genetic associations with LDL-c (<i>β<sub>L</sub></i>), HDL-c (<i>β<sub>H</sub></i>), triglycerides (<i>β<sub>T</sub></i>) and CAD risk (<i>β<sub>Y</sub></i>): estimates of causal log odds ratios <i>β<sub>L</sub></i>, <i>β<sub>H</sub></i>, and <i>β<sub>T</sub></i> (with standard errors).</p

    Summary of recommendations for reporting case-cohort studies, to be used alongside existing STROBE guidelines.

    No full text
    <p>Summary of recommendations for reporting case-cohort studies, to be used alongside existing STROBE guidelines.</p

    Association of lipid score for all lipid-related genetic variants with CAD risk.

    No full text
    <p>Association of coronary artery disease (CAD) risk-increasing alleles of 185 genetic variants with lipid risk score and odds of CAD (brightness corresponds to percentile of chi-squared distribution for heterogeneity test: 98th or higher [brightest red], 95th to 98th, 90th to 95th, below 90th [black]). Note that some points are overlapping. Variants associated with blood pressure or body mass index (P<0.05) are displayed as triangles.</p
    corecore